首页> 外文期刊>The American Journal of Human Genetics >Mutations in ACY1, the gene encoding aminoacylase 1, cause a novel inborn error of metabolism.
【24h】

Mutations in ACY1, the gene encoding aminoacylase 1, cause a novel inborn error of metabolism.

机译:ACY1(编码氨酰酶1的基因)中的突变引起新的先天性代谢错误。

获取原文
获取原文并翻译 | 示例
       

摘要

N-terminal acetylation of proteins is a widespread and highly conserved process. Aminoacylase 1 (ACY1; EC 3.5.14) is the most abundant of the aminoacylases, a class of enzymes involved in hydrolysis of N-acetylated proteins. Here, we present four children with genetic deficiency of ACY1. They were identified through organic acid analyses using gas chromatography-mass spectrometry, revealing increased urinary excretion of several N-acetylated amino acids, including the derivatives of methionine, glutamic acid, alanine, leucine, glycine, valine, and isoleucine. Nuclear magnetic resonance spectroscopy analysis of urine samples detected a distinct pattern of N-acetylated metabolites, consistent with ACY1 dysfunction. Functional analyses of patients' lymphoblasts demonstrated ACY1 deficiency. Mutation analysis uncovered recessive loss-of-function or missense ACY1 mutations in all four individuals affected. We conclude that ACY1 mutations in these children led to functional ACY1 deficiency and excretion of N-acetylated amino acids. Questions remain, however, as to the clinical significance of ACY1 deficiency. The ACY1-deficient individuals were ascertained through urine metabolic screening because of unspecific psychomotor delay (one subject), psychomotor delay with atrophy of the vermis and syringomyelia (one subject), marked muscular hypotonia (one subject), and follow-up for early treated biotinidase deficiency and normal clinical findings (one subject). Because ACY1 is evolutionarily conserved in fish, frog, mouse, and human and is expressed in the central nervous system (CNS) in human, a role in CNS function or development is conceivable but has yet to be demonstrated. Thus, at this point, we cannot state whether ACY1 deficiency has pathogenic significance with pleiotropic clinical expression or is simply a biochemical variant. Awareness of this new genetic entity may help both in delineating its clinical significance and in avoiding erroneous diagnoses.
机译:蛋白质的N末端乙酰化是一个广泛且高度保守的过程。氨基酰化酶1(ACY1; EC 3.5.14)是氨基酰化酶中含量最丰富的一种,是一类与N-乙酰化蛋白水解有关的酶。在这里,我们介绍了四个患有ACY1基因缺陷的儿童。通过使用气相色谱-质谱的有机酸分析对它们进行了鉴定,结果表明尿液中几种N-乙酰化氨基酸的排泄量增加,包括蛋氨酸,谷氨酸,丙氨酸,亮氨酸,甘氨酸,缬氨酸和异亮氨酸的衍生物。尿液样品的核磁共振波谱分析检测到明显的N-乙酰化代谢产物模式,与ACY1功能障碍一致。患者淋巴母细胞的功能分析表明ACY1缺乏。突变分析发现在所有四个受影响的个体中隐性功能丧失或错义ACY1突变。我们得出的结论是,这些儿童中的ACY1突变导致功能性ACY1缺乏和N-乙酰化氨基酸的排泄。但是,关于ACY1缺乏症的临床意义仍然存在疑问。由于非特异性的精神运动延迟(一名受试者),精神运动延迟并伴有mis肌和脊髓空洞萎缩(一名受试者),明显的肌张力减退(一名受试者)以及早期治疗的随访,通过尿液代谢检查确定了ACY1缺乏者生物素酶缺乏症和正常的临床发现(一名受试者)。由于ACY1在鱼类,青蛙,小鼠和人类中在进化上是保守的,并且在人类的中枢神经系统(CNS)中表达,因此可以想到在CNS功能或发育中的作用,但尚待证实。因此,在这一点上,我们无法说明ACY1缺乏症是否具有多效性临床表达的致病意义或仅仅是生化变异。意识到这一新的遗传实体可能有助于描述其临床意义并避免错误诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号